196 related articles for article (PubMed ID: 37965425)
1. Strategic Approach to Heterogeneity Analysis of Cutaneous Adnexal Carcinomas Using Computational Pathology and Genomics.
Nishimura Y; Ryo E; Inoue S; Kawazu M; Ueno T; Namikawa K; Takahashi A; Ogata D; Yoshida A; Yamazaki N; Mano H; Yatabe Y; Mori T
JID Innov; 2023 Nov; 3(6):100229. PubMed ID: 37965425
[TBL] [Abstract][Full Text] [Related]
2. Poroid adnexal skin tumors with YAP1 fusions exhibit similar histopathologic features: A series of six YAP1-rearranged adnexal skin tumors.
Prieto-Granada C; Morlote D; Pavlidakey P; Rodriguez-Waitkus P; Ramirez C; Florento E; Swensen J; Gatalica Z; Stevens TM
J Cutan Pathol; 2021 Sep; 48(9):1139-1149. PubMed ID: 33704800
[TBL] [Abstract][Full Text] [Related]
3. Impact of expert pathology review in skin adnexal carcinoma diagnosis: Analysis of 2573 patients from the French CARADERM network.
Battistella M; Balme B; Jullie ML; Zimmermann U; Carlotti A; Crinquette M; Frouin E; Macagno N; Ortonne N; Lamant L; de la Fouchardiere A; Aubriot-Lorton MH; Durand L; Josselin N; Franck F; Chatelain D; Lemasson G; Algros MP; Durlach A; Machet MC; Courville P; Osio A; Seris A; Mortier L; Jouary T; Cribier B;
Eur J Cancer; 2022 Mar; 163():211-221. PubMed ID: 35090811
[TBL] [Abstract][Full Text] [Related]
4. Value of p63 and podoplanin (D2-40) immunoreactivity in the distinction between primary cutaneous tumors and adenocarcinomas metastatic to the skin: a clinicopathologic and immunohistochemical study of 79 cases.
Plaza JA; Ortega PF; Stockman DL; Suster S
J Cutan Pathol; 2010 Apr; 37(4):403-10. PubMed ID: 20377670
[TBL] [Abstract][Full Text] [Related]
5. NUT Is a Specific Immunohistochemical Marker for the Diagnosis of YAP1-NUTM1-rearranged Cutaneous Poroid Neoplasms.
Macagno N; Kervarrec T; Sohier P; Poirot B; Haffner A; Carlotti A; Balme B; Castillo C; Jullie ML; Osio A; Lehmann-Che J; Frouin E; Battistella M
Am J Surg Pathol; 2021 Sep; 45(9):1221-1227. PubMed ID: 33739783
[TBL] [Abstract][Full Text] [Related]
6. Podoplanin is a highly sensitive and specific marker to distinguish primary skin adnexal carcinomas from adenocarcinomas metastatic to skin.
Liang H; Wu H; Giorgadze TA; Sariya D; Bellucci KS; Veerappan R; Liegl B; Acs G; Elenitsas R; Shukla S; Youngberg GA; Coogan PS; Pasha T; Zhang PJ; Xu X
Am J Surg Pathol; 2007 Feb; 31(2):304-10. PubMed ID: 17255777
[TBL] [Abstract][Full Text] [Related]
7. Surgical management and lymph-node biopsy of rare malignant cutaneous adnexal carcinomas: a population-based analysis of 7591 patients.
Goyal A; Marghitu T; Goyal N; Rubin N; Patel K; Goyal K; O'Leary D; Bohjanen K; Maher I
Arch Dermatol Res; 2021 Oct; 313(8):623-632. PubMed ID: 32965516
[TBL] [Abstract][Full Text] [Related]
8. GATA3 and MYB Expression in Cutaneous Adnexal Neoplasms.
Pardal J; Sundram U; Selim MA; Hoang MP
Am J Dermatopathol; 2017 Apr; 39(4):279-286. PubMed ID: 28323779
[TBL] [Abstract][Full Text] [Related]
9. GATA3 Expression in Normal Skin and in Benign and Malignant Epidermal and Cutaneous Adnexal Neoplasms.
Mertens RB; de Peralta-Venturina MN; Balzer BL; Frishberg DP
Am J Dermatopathol; 2015 Dec; 37(12):885-91. PubMed ID: 26595821
[TBL] [Abstract][Full Text] [Related]
10. Expression of epidermal stem cell markers in skin and adnexal malignancies.
Quist SR; Eckardt M; Kriesche A; Gollnick HP
Br J Dermatol; 2016 Sep; 175(3):520-30. PubMed ID: 26914519
[TBL] [Abstract][Full Text] [Related]
11. Molecular pathology of skin adnexal tumours.
Plotzke JM; Adams DJ; Harms PW
Histopathology; 2022 Jan; 80(1):166-183. PubMed ID: 34197659
[TBL] [Abstract][Full Text] [Related]
12. Fusion-driven cutaneous and superficial mesenchymal and adnexal tumors-A clinicopathologic and molecular study of 15 cases, including a novel case of ACTB::ZMIZ2-rearranged adnexal carcinoma.
Dehner CA; Johnson EF; Wieland CN; Camilleri MJ; Kajdacsy-Balla A; Oliveira AM; Halling KC; Gupta S; Guo R
J Cutan Pathol; 2024 Jul; 51(7):538-548. PubMed ID: 38556256
[TBL] [Abstract][Full Text] [Related]
13. PRAME immunostain expression in sebaceous lesions, cutaneous carcinomas and adnexal structures.
Ng JKM; Choi PCL; Chow C; Li JJX; Chan AWS; Cheung CMT; Ip ECC; Ng HK; To KF
Pathology; 2022 Oct; 54(6):721-728. PubMed ID: 35644638
[TBL] [Abstract][Full Text] [Related]
14. Genetics of adnexal tumors: An update.
Kervarrec T; Sohier P; Pissaloux D; de la Fouchardiere A; Cribier B; Battistella M; Macagno N
Ann Dermatol Venereol; 2023 Sep; 150(3):202-207. PubMed ID: 37270318
[TBL] [Abstract][Full Text] [Related]
15. Retrospective study of rare cutaneous malignant adnexal tumors of the head and neck in a tertiary care cancer hospital: a case series.
Waqas O; Faisal M; Haider I; Amjad A; Jamshed A; Hussain R
J Med Case Rep; 2017 Mar; 11(1):67. PubMed ID: 28284233
[TBL] [Abstract][Full Text] [Related]
16. Adnexal skin tumors in Zaria, Nigeria.
Samaila MO
Ann Afr Med; 2008 Mar; 7(1):6-10. PubMed ID: 18702242
[TBL] [Abstract][Full Text] [Related]
17. Surgery and Adjuvant Radiation for High-risk Skin Adnexal Carcinoma of the Head and Neck.
Wang LS; Handorf EA; Wu H; Liu JC; Perlis CS; Galloway TJ
Am J Clin Oncol; 2017 Aug; 40(4):429-432. PubMed ID: 25599317
[TBL] [Abstract][Full Text] [Related]
18. Survival after resection of cutaneous adnexal carcinomas with eccrine differentiation: risk factors and trends in outcomes.
Avraham JB; Villines D; Maker VK; August C; Maker AV
J Surg Oncol; 2013 Jul; 108(1):57-62. PubMed ID: 23677677
[TBL] [Abstract][Full Text] [Related]
19. Deep learning based histological classification of adnex tumors.
Jansen P; Arrastia JL; Baguer DO; Schmidt M; Landsberg J; Wenzel J; Emberger M; Schadendorf D; Hadaschik E; Maass P; Griewank KG
Eur J Cancer; 2024 Jan; 196():113431. PubMed ID: 37980855
[TBL] [Abstract][Full Text] [Related]
20. A potential role for targeted therapy in a subset of metastasizing adnexal carcinomas.
Dias-Santagata D; Lam Q; Bergethon K; Baker GM; Iafrate AJ; Rakheja D; Hoang MP
Mod Pathol; 2011 Jul; 24(7):974-82. PubMed ID: 21423156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
